z-logo
Premium
Can thrombotic events be a major concern in hepatocellular carcinoma patients under systemic treatment during SARS‐Cov‐2?
Author(s) -
Fonseca Leonardo,
Carrilho Flair José
Publication year - 2020
Publication title -
liver international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.873
H-Index - 110
eISSN - 1478-3231
pISSN - 1478-3223
DOI - 10.1111/liv.14545
Subject(s) - hepatocellular carcinoma , covid-19 , medicine , systemic risk , betacoronavirus , gastroenterology , virology , intensive care medicine , disease , financial crisis , outbreak , infectious disease (medical specialty) , economics , macroeconomics

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom